about
Frontotemporal Lobar Degeneration and MicroRNAsHydrogel-based nanocomposites and mesenchymal stem cells: a promising synergistic strategy for neurodegenerative disorders therapySORL1 Gene is Associated with the Conversion from Mild Cognitive Impairment to Alzheimer's DiseaseDJ-1 modulates alpha-synuclein aggregation state in a cellular model of oxidative stress: relevance for Parkinson's disease and involvement of HSP70.A polymorphic variant of the insulin-like growth factor 1 (IGF-1) receptor correlates with male longevity in the Italian population: a genetic study and evaluation of circulating IGF-1 from the "Treviso Longeva (TRELONG)" study.Rs5848 variant influences GRN mRNA levels in brain and peripheral mononuclear cells in patients with Alzheimer's disease.Failure to replicate an association of rs5984894 SNP in the PCDH11X gene in a collection of 1,222 Alzheimer's disease affected patients.One single method to produce native and Tat-fused recombinant human α-synuclein in Escherichia coli.A novel study and meta-analysis of the genetic variation of the serotonin transporter promoter in the italian population do not support a large effect on Alzheimer's disease risk.Interleukin-1α, interleukin-1β and tumor necrosis factor-α genetic variants and risk of dementia in the very old: evidence from the "Monzino 80-plus" prospective study.Interleukin-6 plasma level increases with age in an Italian elderly population ("The Treviso Longeva"-Trelong-study) with a sex-specific contribution of rs1800795 polymorphismEpistasis between IL1A, IL1B, TNF, HTR2A, 5-HTTLPR and TPH2 variations does not impact alcohol dependence disorder features.Sirtuins as novel targets for Alzheimer's disease and other neurodegenerative disorders: experimental and genetic evidence.Neuroprotective properties of resveratrol in different neurodegenerative disorders.Macroautophagy and the proteasome are differently involved in the degradation of alpha-synuclein wild type and mutated A30P in an in vitro inducible model (PC12/TetOn).Recombinant human Tat-Hsp70-2: A tool for neuroprotection.Genetic Variants Within Key Nodes of the Cascade of Antipsychotic Mechanisms: Effects on Antipsychotic Response and Schizophrenia Psychopathology in a Naturalistic Treatment Setting in Two Independent Korean and Italian Samples.Cross-linked poly(acrylic acids) microgels and agarose as semi-interpenetrating networks for resveratrol release.Clinical and genetic factors associated with suicide in mood disorder patients.The role of single-nucleotide variants of the energy metabolism-linked genes SIRT3, PPARGC1A and APOE in amyotrophic lateral sclerosis risk.Sirtuin 2 Inhibition Improves Cognitive Performance and Acts on Amyloid-β Protein Precursor Processing in Two Alzheimer's Disease Mouse Models.Rosuvastatin and thapsigargin modulate γ-secretase gene expression and APP processing in a human neuroglioma model.The SIRT1 activator resveratrol protects SK-N-BE cells from oxidative stress and against toxicity caused by alpha-synuclein or amyloid-beta (1-42) peptide.Association between CSF biomarkers, hippocampal volume and cognitive function in patients with amnestic mild cognitive impairment (MCI).Protective effect of TAT-delivered alpha-synuclein: relevance of the C-terminal domain and involvement of HSP70.Clinical and biomarker profiling of prodromal Alzheimer's disease in workpackage 5 of the Innovative Medicines Initiative PharmaCog project: a 'European ADNI study'.Vitamin B12 levels in Alzheimer's disease: association with clinical features and cytokine production.An APOE haplotype associated with decreased ε4 expression increases the risk of late onset Alzheimer's disease.Impact of 5-HTTLPR polymorphism on alexithymia in alcoholic patients after detoxification treatment.Pharmacogenomics in Alzheimer's disease: a genome-wide association study of response to cholinesterase inhibitors.Melatonin and the Charlson Comorbidity Index (CCI): the Treviso Longeva (Trelong) study.Early-onset Alzheimer disease in an Italian family with presenilin-1 double mutation E318G and G394V.Association between Sirtuin 2 gene rs10410544 polymorphism and depression in Alzheimer's disease in two independent European samples.Lack of association between interleukin-1 alpha rs1800587 polymorphism and Alzheimer's disease in two Independent European samples.Serotonin transporter gene polymorphic element 5-HTTLPR increases the risk of sporadic Parkinson's disease in Italy.The serotonin transporter promoter polymorphic region is not a risk factor for Alzheimer's disease related behavioral disturbances.Pleiotropic genes in psychiatry: Calcium channels and the stress-related FKBP5 gene in antidepressant resistance.Body mass index, cognition, disability, APOE genotype, and mortality: the "Treviso Longeva" Study.Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patients.TPH2 gene variants and anxiety during alcohol detoxification outcome.
P50
Q26768177-6C32CE8C-AACA-4B2C-9E27-5E62D563C6D7Q27027614-4932CF15-DB10-4E58-A1F4-19E0E7D3429AQ28260619-E8134138-858F-4003-9FFD-DA804D418369Q33326619-7C65B77A-219D-475A-A062-083BE8615C24Q33449905-4AEFFA9A-C20B-4AA1-9DF7-D7FE1729DA48Q33742148-FB36B6DA-2FC8-4CAE-8F38-01F41F22E60FQ34121245-3A295B32-6AF5-4CC3-A511-AA286945C309Q34655246-A5EAD8AF-E56D-410A-98E1-1F1D98AEAA94Q35029787-7F127B5E-1F55-49F4-A9EF-FD9A4CEB6B61Q35853678-1D025FBF-6E55-47A8-88F5-D6A1D90D947FQ37220813-95DB6782-1FFC-411D-A6F1-CA416BE5785BQ37335368-02A8416D-79CA-48A6-A8F9-9552C96785ABQ37671440-4817BD54-B0FD-403D-BD12-9E0D50F2067EQ37789699-A6A9D700-AF51-4B2F-8EF6-2A5EBEBF6354Q38647359-619D9A94-1B08-4F17-9591-0A9063D79B6DQ38758559-0D76EB3B-B9ED-456B-BA71-FDFC00B91BDCQ38783824-A6BE66E9-F2C4-47D8-8513-6759EADC1C3EQ38921280-7EAD4E5D-65E4-483F-990E-ADDE2B5E480DQ38936602-D110665B-D8D4-42F2-8E50-BC6B9BD357DBQ38941137-5656BCE8-5284-4EFE-B831-FE55DD23035BQ39636393-EF40F2FF-2D74-4E13-BE1A-D0D6C2C7EEC7Q39638936-59A781A5-8BF9-46BC-B332-8B4A221A5572Q39832644-98EA7547-095D-4837-8628-A319C18028C0Q40339348-4F56D814-81A0-4350-B585-23E1399D76D5Q40519448-C9389B82-E608-4D96-AD6D-074CF9AADA8CQ40873275-6182CA5C-8065-4248-94A5-E4BE51F29FACQ42466531-25F17A1A-9EBA-400E-BED5-11B62EC73020Q43643907-6A5C3D40-A2B7-41F6-90A9-9C71BF76921BQ43959468-055B9541-1A21-44B9-9BF8-F532F60521C3Q44116778-11965270-A494-445D-A71E-CE38BB4D79DBQ44801119-1C3C170D-0479-415F-8F6A-B6EA27A911E1Q45026539-1D19259B-4690-4B64-907E-E72054AF8A86Q45156606-AC1C9C76-2D57-4BC3-897E-129D6D01B430Q45819466-B95DBEF4-F3CE-432C-B9F4-CE230A9155DCQ45841564-407F4910-C9F9-4286-BE35-B33C9BC7A5EDQ45922650-3C05B7E1-C036-4F4A-BB38-B9726C2A36EEQ45945144-4453EF9D-796C-4F03-B39E-BF22AAD90685Q45999932-E1F7CB57-D349-4E18-B869-08A821BEC924Q46051996-839295D0-9392-4173-88D6-DBA8DA0789CFQ46053520-9A5887FD-670B-455F-91C5-CD69EFA10D60
P50
description
researcher ORCID: 0000-0002-7050-6723
@en
name
Diego Albani
@ast
Diego Albani
@en
Diego Albani
@es
Diego Albani
@nl
Diego Albani
@sl
type
label
Diego Albani
@ast
Diego Albani
@en
Diego Albani
@es
Diego Albani
@nl
Diego Albani
@sl
altLabel
DIEGO ALBANI
@en
prefLabel
Diego Albani
@ast
Diego Albani
@en
Diego Albani
@es
Diego Albani
@nl
Diego Albani
@sl
P1053
I-5183-2018
P106
P1153
6603839904
P21
P31
P496
0000-0002-7050-6723